MA/MS in Drug Innovation

This Master's programme centres on improving and managing small molecule and biomolecular drugs, drawing on bioinformatics, chemistry, biology, physics, and medicine to look for new approaches to diseases that currently have no cure. Students develop skills relevant to new vaccines, gene therapeutics, the use of organoids, and medical nutrition, and are trained to set new benchmarks and methods for assessing a drug's quality, how effective and safe it is, and how well it performs. Its translational approach spans work on the causes of disease, involvement in developing a new drug, and investigation of a drug's long-term safety.